Rhabdomyosarcoma, Alveolar
"Rhabdomyosarcoma, Alveolar" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of RHABDOMYOSARCOMA occurring mainly in adolescents and young adults, affecting muscles of the extremities, trunk, orbital region, etc. It is extremely malignant, metastasizing widely at an early stage. Few cures have been achieved and the prognosis is poor. "Alveolar" refers to its microscopic appearance simulating the cells of the respiratory alveolus. (Holland et al., Cancer Medicine, 3d ed, p2188)
MeSH Number(s)
C04.557.450.590.550.660.665
C04.557.450.795.550.660.665
Concept/Terms
Rhabdomyosarcoma, Alveolar- Rhabdomyosarcoma, Alveolar
- Alveolar Rhabdomyosarcoma
- Alveolar Rhabdomyosarcomas
- Rhabdomyosarcomas, Alveolar
- Rhabdomyosarcoma 2
Below are MeSH descriptors whose meaning is more general than "Rhabdomyosarcoma, Alveolar".
Below are MeSH descriptors whose meaning is more specific than "Rhabdomyosarcoma, Alveolar".
This graph shows the total number of publications written about "Rhabdomyosarcoma, Alveolar" by people in Harvard Catalyst Profiles by year, and whether "Rhabdomyosarcoma, Alveolar" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 0 | 1 | 1 |
1996 | 1 | 0 | 1 |
1997 | 1 | 0 | 1 |
1999 | 1 | 1 | 2 |
2000 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2002 | 1 | 0 | 1 |
2004 | 1 | 0 | 1 |
2006 | 1 | 0 | 1 |
2007 | 2 | 0 | 2 |
2011 | 1 | 2 | 3 |
2013 | 2 | 0 | 2 |
2014 | 2 | 0 | 2 |
2015 | 1 | 0 | 1 |
2016 | 2 | 0 | 2 |
2017 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
2021 | 2 | 0 | 2 |
2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Rhabdomyosarcoma, Alveolar" by people in Profiles.
-
A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma. Clin Cancer Res. 2022 09 15; 28(18):3950-3957.
-
Therapeutic targeting of ATR in alveolar rhabdomyosarcoma. Nat Commun. 2022 07 25; 13(1):4297.
-
MYOD1 as a prognostic indicator in rhabdomyosarcoma. Pediatr Blood Cancer. 2021 09; 68(9):e29085.
-
A method to culture human alveolar rhabdomyosarcoma cell lines as rhabdospheres demonstrates an enrichment in stemness and Notch signaling. Biol Open. 2021 02 09; 10(2).
-
The Transcriptional Coactivator TAZ Is a Potent Mediator of Alveolar Rhabdomyosarcoma Tumorigenesis. Clin Cancer Res. 2018 06 01; 24(11):2616-2630.
-
Sinonasal Tract Alveolar Rhabdomyosarcoma in Adults: A Clinicopathologic and Immunophenotypic Study of Fifty-Two Cases with Emphasis on Epithelial Immunoreactivity. Head Neck Pathol. 2018 Jun; 12(2):181-192.
-
Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 Dec; 64(12).
-
Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects. Oncotarget. 2016 Sep 27; 7(39):62814-62835.
-
Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Apr; 63(4):634-9.
-
Severe Tumor Lysis Syndrome and Acute Pulmonary Edema Requiring Extracorporeal Membrane Oxygenation Following Initiation of Chemotherapy for Metastatic Alveolar Rhabdomyosarcoma. Pediatr Blood Cancer. 2016 May; 63(5):928-30.